Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Oct, 1 2025
May, 21 2026
Apr, 23 2026
Aug, 13 2026
Oct, 15 2025